Literature DB >> 33851976

Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer.

Leah L Thompson1, Jaewon Yoon1, Nira A Krasnow1, Michael S Chang1, Edward B Li1, Devon E McMahon1, Steven T Chen1.   

Abstract

Entities:  

Year:  2021        PMID： 33851976      PMCID： PMC8047752          DOI： 10.1001/jamadermatol.2021.0727

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  5 in total

1.  High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma.

Authors:  Alexander T Faje; Donald Lawrence; Keith Flaherty; Christine Freedman; Riley Fadden; Krista Rubin; Justine Cohen; Ryan J Sullivan
Journal:  Cancer       Date:  2018-07-05       Impact factor: 6.860

2.  Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.

Authors:  Troy Z Horvat; Nelly G Adel; Thu-Oanh Dang; Parisa Momtaz; Michael A Postow; Margaret K Callahan; Richard D Carvajal; Mark A Dickson; Sandra P D'Angelo; Kaitlin M Woo; Katherine S Panageas; Jedd D Wolchok; Paul B Chapman
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

3.  The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.

Authors:  Maria Del Castillo; Fabian A Romero; Esther Argüello; Chrisann Kyi; Michael A Postow; Gil Redelman-Sidi
Journal:  Clin Infect Dis       Date:  2016-08-07       Impact factor: 9.079

4.  Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.

Authors:  Leah L Thompson; Nira A Krasnow; Michael S Chang; Jaewon Yoon; Edward B Li; Nicole J Polyakov; Gabriel E Molina; Jordan T Said; Kevin Huang; Juhi R Kuchroo; Andrea N Hinton; Kerry L Reynolds; Steven T Chen
Journal:  JAMA Dermatol       Date:  2021-05-01       Impact factor: 10.282

5.  Treatment Outcomes of Immune-Related Cutaneous Adverse Events.

Authors:  Gregory S Phillips; Jennifer Wu; Matthew D Hellmann; Michael A Postow; Naiyer A Rizvi; Azael Freites-Martinez; Donald Chan; Stephen Dusza; Robert J Motzer; Jonathan E Rosenberg; Margaret K Callahan; Paul B Chapman; Larisa Geskin; Adriana T Lopez; Vanessa A Reed; Gabriella Fabbrocini; Maria Carmela Annunziata; Oluwaseun Kukoyi; Aliyah Pabani; Chih-Hsun Yang; Wen-Hung Chung; Alina Markova; Mario E Lacouture
Journal:  J Clin Oncol       Date:  2019-06-19       Impact factor: 50.717
  5 in total
  1 in total

1.  Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study.

Authors:  Giulia Gullo; Marco Rubatto; Paolo Fava; Matteo Brizio; Luca Tonella; Simone Ribero; Matelda Medri; Gianluca Avallone; Luca Mastorino; Maria Teresa Fierro; Ignazio Stanganelli; Pietro Quaglino
Journal:  Dermatol Ther       Date:  2022-05-10       Impact factor: 3.858
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.